Linked Life Data

15963059

Source:http://linkedlifedata.com/resource/pubmed/id/15963059

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2005-6-20
pubmed:abstractText
There is no consensus as to the optimal postoperative treatment of patients with clinically nonfunctioning pituitary adenomas (NFPA) in whom total tumour removal has not been achieved. In this study we assessed whether dopamine agonist (DA) treatment can prevent postoperative remnant enlargement in NFPA.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0300-0664
pubmed:author
pubmed:issnType
Print
pubmed:volume
63
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
39-44
pubmed:dateRevised
2005-11-17
pubmed:meshHeading
pubmed-meshheading:15963059-Adenoma, pubmed-meshheading:15963059-Adult, pubmed-meshheading:15963059-Aged, pubmed-meshheading:15963059-Bromocriptine, pubmed-meshheading:15963059-Cohort Studies, pubmed-meshheading:15963059-Dopamine Agonists, pubmed-meshheading:15963059-Female, pubmed-meshheading:15963059-Follicle Stimulating Hormone, pubmed-meshheading:15963059-Humans, pubmed-meshheading:15963059-Luteinizing Hormone, pubmed-meshheading:15963059-Magnetic Resonance Imaging, pubmed-meshheading:15963059-Male, pubmed-meshheading:15963059-Middle Aged, pubmed-meshheading:15963059-Neoplasm, Residual, pubmed-meshheading:15963059-Pituitary Neoplasms, pubmed-meshheading:15963059-Postoperative Period, pubmed-meshheading:15963059-Survival Analysis, pubmed-meshheading:15963059-Thyrotropin-Releasing Hormone, pubmed-meshheading:15963059-Treatment Outcome
pubmed:year
2005
pubmed:articleTitle
Postoperative treatment of clinically nonfunctioning pituitary adenomas with dopamine agonists decreases tumour remnant growth.
pubmed:affiliation
Institute of Endocrinology, Metabolism and Hypertension, Tel Aviv-Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. greenman@tasmc.health.gov.il
pubmed:publicationType
Journal Article